Hyderabad, India, March 27, 2017 -- The report “Biomarkers Market: Types (Biomarkers: Disease & related, Imaging, Others) Application (Drug Discovery, Bioinformatics, Others) Therapeutic Areas (Cardiology, Neurology, Others) Products (Hormones, Enzymes, Others) End Users (Hospitals, Others)-Forecast (2017-2022)”, published by IndustryARC, estimates that rising demand for personalized medicine, usefulness in drug development and increased investment in research and development will propel the market significantly in North America.
Browse numerous 20 Market Tables and 50 Figures spread through 85 Pages and an in-depth TOC on “Biomarkers Market 2017-2022”
http://industryarc.com/Report/9593/global-biomarkers-market.html
Scope & Regional Forecast of the Biomarkers Market:
Biomarkers are measurable characteristics of an organism that reflect a particular physiological state. They are biological molecules which act as indicators of a particular disease or treatment condition and measured in biological samples such as blood, urine, and saliva. Biomarkers are used to predict the severity of a disease, assess the effectiveness of a therapy, measure the drug response rate and detect adverse drug reactions. They also aid in the development of new drug therapies and can also be used to assess the functioning of the internal organs while providing assistance to clinicians in decision making.
Request Sample PDF Brochure @ http://industryarc.com/pdfdownload.php?id=9593
The high cost associated with the discovery and development, a time consumed and the stringent regulations are few of the challenges of this industry. The industry is growing at a rapid pace due to the increased adoption of biomarkers. In the future biomarkers will not just be used for the detection, prevention, and treatment of cancers but also other diseases. The prime factor for the development of the biomarkers market is the advancement in technology such as genome sequencing.
Inquiry before buying report @ http://industryarc.com/inquiry-before-buying.php?id=9593
Prominent Segmentations Involved in the Biomarkers Market:
The Biomarkers Market can be broken down into various segmentations on the basis of -
- Type: Disease-related biomarkers (Diagnostic biomarker, Prognostic biomarker), Drug-related biomarkers, Imaging biomarkers, Molecular biomarkers, Surrogate biomarkers and others.
- Applications: Drug discovery & Development, Molecular diagnostics, Genetic studies, Clinical Trials, Bioinformatics and Others.
- Therapeutic areas: Oncology, Cardiology, Immunology, Neurology and Others.
- Products: Hormones, Enzymes, Antibodies, Gene products and others.
- End Users: Pharmaceutical Companies, Hospitals, Research Institutes, CROs and Diagnostic Labs.
- Geographic Location: Americas, Europe, Asia-Pacific and Rest of the world.
Some of the sample companies profiled in the Biomarkers Market report are as follows:
- Enzo Biochem
- EKF Diagnostics Holdings plc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories
- Roche Diagnostic Limited
- Siemens Healthcare
- Abbott Laboratories Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies Inc.
- G.E. Healthcare Inc.
Why buy this report?
- Get a detailed picture of the Biomarkers Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase Biomarkers Market Report @ http://industryarc.com/purchasereport.php?id=9593
Browse Related Reports:
Synthetic Biology Market: By Tool (XNAS, Chassis Organisms) By Technology (Bioinformatics, DNA sequencing, integrated systems) By Products (Core products, Enabled Products) By Application (Agriculture, Food, Biofuel, Medicine)-Forecast (2016- 2021)
http://industryarc.com/Report/15142/synthetic-biology-market.html
Genomics Market: Product Types (DNA Microarrays, Sequencers, PCR); Services (Bioinformatics, DNA Sample Sequencing, De Novo, SNPS, Gene Expression) and Geography - Forecast (2017-2022)
http://industryarc.com/Report/1275/genomics-market-analysis-and-forecast-report.html
About IndustryARC:
IndustryARC is a research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.
We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Media Contact
Mr. Sanjay Matthews
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc
Know more about IndustryARC Events: http://industryarc.com/events.php


Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 



